Clinical value of Lipoprotein(a) combined with CatLet coronary score in predicting adverse events after emergency PCI for AMI patients
PLOS One · 2026
DOI: 10.1371/journal.pone.0342704 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2026. Verfasst von Mengru Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Bozhou Hospital Affiliated to Anhui Medical University, Bozhou City, Anhui Province, China. Hauptthemen laut MEDLINE: Lipoprotein(a), Myocardial Infarction, Percutaneous Coronary Intervention. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Key Technologies Research and Development Program of Anhui Province, Henan Provincial Science and Technology Research Project.
Themen: Patientensicherheit
Abstract (Originalsprache)
Background and aims Lipoprotein(a) [Lp(a)] promotes atherosclerotic plaque vulnerability through pro-inflammatory and thrombogenic pathways, while the CatLet© angiographic score quantifies coronary lesion complexity. We hypothesized that their integration would improve prognostication in acute myocardial infarction (AMI) after emergency percutaneous coronary intervention (ePCI).
Methods
In this retrospective cohort, 307 AMI patients undergoing successful ePCI (2020–2022) were stratified by 1-year major adverse cardiovascular/cerebrovascular events (MACCE). Serum Lp(a) and troponin I were measured post-admission. CatLet© and Gensini scores were assessed by blinded analysts. Multivariable logistic regression and ROC analyses evaluated predictive performance.
Results
MACCE patients (n = 78) exhibited higher Lp(a) (135.99 ± 33.07vs. 123.35 ± 42.70nmol/L, P = 0.0178) and CatLet© scores (33.58 ± 9.04vs. 30.80 ± 8.24, P = 0.0012) versus controls. Lp(a) (OR=2.339,95%CI:1.519–3.603, P < 0.001) and CatLet© score (OR=1.092, 95%CI:1.027–1.161, P = 0.005) independently predicted MACCE. The combined model Lp(a)≥70.70 nmol/L + CatLet© ≥ 18.6) significantly outperformed individual markers (AUC 0.862 [95%CI:0.83–0.96] vs. 0.780/0.833; DeLong’s test confirmed the superiority of the combined model over individual predictors (P = 0.0089, Z = 2.64 vs. Lp(a); P = 0.034, Z = 2.12 vs. CatLet© score), with 88% sensitivity and 83% specificity.
Conclusions
The Lp(a)-CatLet© synergy enhances MACCE risk stratification in ePCI-treated AMI, reflecting complementary pathobiological (Lp(a)-driven plaque vulnerability) and anatomical (CatLet©-quantified complexity) pathways. This dual-parameter approach could support post-PCI risk stratification and follow-up planning.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Bozhou Hospital Affiliated to Anhui Medical University, Bozhou City, Anhui Province, China.
- Department of Cardiology, Department of Cardiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, People's Republic of China.
ORCID-Profile: Sheng Tu
Förderung
- Key Technologies Research and Development Program of Anhui Province
- Henan Provincial Science and Technology Research Project
Zitieren
APA
Wang, M., Hu, F., Jiang, R., & Tu, S. (2026). Clinical value of Lipoprotein(a) combined with CatLet coronary score in predicting adverse events after emergency PCI for AMI patients. PLOS One. https://doi.org/10.1371/journal.pone.0342704
Vancouver
Wang M, Hu F, Jiang R, Tu S. Clinical value of Lipoprotein(a) combined with CatLet coronary score in predicting adverse events after emergency PCI for AMI patients. PLOS One. 2026. doi:10.1371/journal.pone.0342704
BibTeX
@article{Wang2026,
author = {Wang, Mengru and Hu, Fudong and Jiang, Rongyan and Tu, Sheng},
title = {Clinical value of Lipoprotein(a) combined with CatLet coronary score in predicting adverse events after emergency PCI for AMI patients},
journal = {PLOS One},
year = {2026},
doi = {10.1371/journal.pone.0342704}
}
EUVIMED